Literature DB >> 2314537

Renal hemodynamic and tubular response to furosemide in man during normal and restricted sodium intake.

J J Beutler1, W H Boer, H A Koomans, E J Dorhout Mees.   

Abstract

To investigate the factors determining the natriuretic response to furosemide (F) during Na restriction, we performed clearance studies in 7 healthy humans on a daily Na intake of 200 and 20 mmol. The maximum urine flow during water loading (Vmax) and simultaneous F administration was used as index of tubular fluid output from the proximal tubules. The F-induced natriuresis was only moderately reduced during Na restriction (Na excretion on low vs. normal Na intake: 4.28 +/- 0.25 vs. 4.94 +/- 0.25 mmol/min; p less than 0.05). The diminished natriuresis was mainly due to a significant fall in Na delivery to Henle's loop of 0.51 +/- 0.10 mmol/min which was either caused by a decrease in filtered Na load or a rise in fractional proximal reabsorption. Fractional distal Na reabsorption was less suppressible by F during Na restriction, but this contributed relatively little (0.15 +/- 0.11 mmol/min) to the total reduction in Na excretion (0.66 +/- 0.10 mmol/min). The F-induced increases in uric acid, phosphate, and bicarbonate excretion suggest an additional proximal site of action of F. This was confirmed by a rise in lithium clearance (CLi), another alleged index of tubular fluid delivery from the proximal tubules. However, the magnitude of the rise in CLi to values markedly exceeding Vmax suggest that CLi overestimates tubular fluid delivery to Henle's loop during F administration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2314537     DOI: 10.1159/000185856

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

Review 1.  Clinical problems of diuretic treatment.

Authors:  D Fliser; E Ritz
Journal:  Clin Investig       Date:  1994-09

2.  Continuous renal replacement therapy versus furosemide for management of kidney impairment in heart transplant recipients with volume overload.

Authors:  Seyed Mohsen Mirhosseini; Mohammad Fakhri; Shadi Asadollahi; Zargham Hossein Ahmadi; Farin Rashid Farokhi; Mohammad Reza Boloursaz; Mohammad Reza Masjedi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-05

Review 3.  Role of adenosine antagonism in the cardio-renal syndrome: pathophysiology and therapeutic potential.

Authors:  Venkataraman Rajaram; Jacob Joseph
Journal:  Curr Heart Fail Rep       Date:  2007-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.